ARMP
ARMP
AMEX · Biotechnology

Armata Pharmaceuticals Inc

$8.05
-0.15 (-1.83%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +116.8% upside
Low Target $10.78
Average Target $17.45
High Target $19.60
Current Price $8.05
Current
$8.05
Target
$17.45
$10.78 $17.45 avg $19.60
Scenario Analysis
Bear Case
$10.78
33.9%
Low target
Base Case
$17.45
+116.8%
Avg target
Bull Case
$19.60
+143.5%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$16.34
-50.7% from high
52-Week Low
$1.17
+588.0% from low
Target vs 52W High
$17.45
+6.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +20.5%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.2%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +178.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.1%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -88.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -23.9%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.0%